INTRODUCTION
This report gives coverage of the diabetes device market which incorporates both diagnostic and insulin delivery devices. Epidemiology of this disease is forecast to 2030 and the various market segments of the market are forecast through to 2016. The report includes detailed company profiles of the established key emerging companies. The regulatory environment and other key events are assessed.

FEATURES AND BENEFITS
Identify the market potential of the diabetes device market and the various diabetes device segments.
Gain a quick and comprehensive understanding of the innovations shaping the diabetes device market.
Identify the key innovations being developed by both emerging and established players and assess their potential.
Benchmark performance in terms of revenue growth and product launch capabilities against the leading diabetes device companies.
Learn from the strategies of leading diabetes device companies to target future growth areas, avoid their mistakes, and replicate their successes

HIGHLIGHTS
The global diabetes device market is projected to reach $19.9bn by 2016, growing at a CAGR of 6.1%. Continuous glucose monitoring systems will emerge as the fastest growing market segment over this period as innovative systems with improved accuracy are introduced.
The market for insulin pen devices is projected to grow at a CAGR of 14% to 2016 driven by the rapid uptake of pre-filled insulin pens and increased penetration of insulin pens in the US, where these devices are underutilized as compared to Europe.
The market is very concentrated among the leading players. The top three companies controlled more than 50% of the market. Of the top five companies, all except for Bayer have utilized acquisitions to get access to innovative technologies. The emergence of several innovative, specialist companies has challenged the dominance of the leading players.

YOUR KEY QUESTIONS ANSWERED
Which will be the largest growth opportunities in the diabetes device market?
Which companies are leading the various segments of the diabetes devices market?
What are the new advances in diabetes devices and which of them offer the most significant potential in the future?
How have the leading companies established their market leading positions in the various segments of the diabetes devices market?
How have the leading companies in the diabetes device market performed financially over the last three years?

EXECUTIVE SUMMARY

Overview of the diabetes devices market
Segmentation of the diabetes device market
Innovations in the diabetes device market
Key players in the diabetes device market
Developments in the diabetes device market
Overview of the diabetes devices market
Summary
Introduction
Type-1 diabetes
Type-2 diabetes
Pre-gestational diabetes
Gestational diabetes mellitus (GDM)
Epidemiology
Economic burden of diabetes
Market size of the global diabetes devices
Forecast market size of global diabetes devices
Drivers of the global diabetes devices market
Increase in the awareness of diabetes
Demand for regular monitoring of glucose
Demand for tight regulation of insulin levels in patients
Increase in the usage of self administered and patient convenient devices
Use of new devices as a strategy for differentiation and life cycle management
Impending patent expiries of insulin products and the growth of the biosimilars market
Resistors of the global diabetes devices market
Development of oral insulin products
Lack of reimbursement for new devices
High failure and recall rates for insulin pumps
Segmentation of the diabetes device market
Summary
Glucose monitoring devices
Regular glucose monitoring devices
Continuous glucose monitoring (CGM) devices
Insulin delivery devices
Insulin pumps
Insulin pens
Insulin syringes
Inhaled insulin devices - case study on Exubera
Innovations in the diabetes device market
Summary
Introduction
Advances in glucose monitoring devices
Regular glucose monitoring
Non-invasive glucose monitoring
Diabetes screening
Advances in insulin delivery devices
Insulin pumps
Insulin pens
Artificial pancreas – closed loop systems
Key players in the diabetes device market
Summary
Introduction
Leading players
Roche
Johnson & Johnson (J&J)
Bayer
Abbott
Medtronic
Becton Dickinson (BD)
Ypsomed
Insulet
DexCom
Emerging players and OEMs
Agamatrix
Taidoc
EPS Biotechnology
Tyson Bioresearch
Bionime
Developments in the diabetes device market
Summary
Introduction
Regulatory and market developments impacting the market
US FDA looking to improve standards of accuracy for glucose meters
Stricter regulatory requirements for infusion pumps from the US FDA
Changes in PMN pathway
Comparative effectiveness research (CER)
Medical device excise tax
Mergers and acquisitions
Alliances and partnerships
New product approvals
Appendix
Scope
Methodology
Glossary/Abbreviations
References

TABLES

Table: Epidemiology of diabetes by region, 2010–2030
Table: Top 20 countries by diabetes burden in 2030
Table: Incidence and prevalence of Type-1 diabetes in 0–14 year age group, 2010
Table: Healthcare expenditure for diabetes by region, 2010–2030
Table: Top 20 countries by healthcare expenditure on diabetes in 2030
Table: Segment wise historical market size of global diabetes devices, 2005–10
Table: Segment wise forecasted market size of global diabetes devices, 2010–16
Table: Recommendations for SMBG frequency
Table: Key regular glucose monitoring devices
Table: Key marketed CGM devices
Table: Key insulin pump devices
Table: Global insulin pen market size ($m) by segment, 2005–10
Table: Forecast global market size ($m) of insulin pens by segment, 2010–16
Table: Leading insulin products utilizing pen delivery systems
Table: Market shares of leading companies in the global diabetes device market, 2009
Table: Global diabetes device revenues of leading companies, ($m), 2007–2009
Table: Presence of leading players in the various diabetes device segments
Table: Roche diabetes devices revenue performance ($m), 2005–2010
Table: J&J diabetes devices revenue performance ($m), 2005–2009
Table: Bayer diabetes devices revenue performance ($m), 2005–2010
Table: Abbott diabetes devices revenue performance ($m), 2005–2010
Table: Medtronic diabetes devices revenue performance ($m), 2005–2010
Table: BD diabetes devices revenue performance ($m), 2005–2010
Table: Ypsomed diabetes devices revenue performance ($m), 2008–2010
Table: Insulet diabetes devices revenue performance ($m), 2005–2010
Table: Dexcom diabetes devices revenue performance ($m), 2007–2010
Table: Key acquisitions in the diabetes devices market, 2000–2010
Table: Partnerships in the global diabetes device market, 2007–2011
Table: Partnerships in the global diabetes device market, 2007–2011 (continued)

FIGURES
Figure: Working reaction of a glucometer
Figure: Global regular glucose monitoring devices market size ($bn), 2005–10
Figure: Forecast global market size of regular glucose monitoring devices ($bn), 2010–16
Figure: Leading players’ share of the regular glucose monitoring device market, 2010
Figure: Components of a CGM device
Figure: Global CGM devices market size ($m), 2005–10
Figure: Forecast global market size of CGM devices ($m), 2010–16
Figure: Leading players’ share of the CGM device market, 2010
Figure: Block diagram of an insulin infusion pump
Figure: Global regular insulin infusion pumps market size ($m), 2005–10
Figure: Forecast global market size of insulin infusion pumps ($m), 2010–16
Figure: Leading players’ share of the insulin infusion pump market, 2010
Figure: Components of a typical insulin pen
Figure: Global insulin pen market size ($m), 2005–10
Figure: Forecast global market size of insulin pens ($m), 2010–16
Figure: Components of a typical insulin syringe
Figure: Global insulin syringe market size ($m), 2005–10
Figure: Forecast global market size of insulin syringes ($m), 2010–16
Figure: Dreamboat Inhaler device for Afrezza
Figure: Components of the GlucoTrack device
Figure: The Sentris-100 device
Figure: Scout DS diabetes screening system
Figure: Flow chart for the EyeTel Retinal Imaging Telemetry System
Figure: Patch pumps under various stages of development
Figure: OmniPod Insulin Management System
Figure: Solo MicroPump
Figure: Cellnovo insulin pump
Figure: JewelPUMP
Figure: Components of the ADI Insulin Pump
Figure: V-Go disposable insulin delivery device
Figure: CeQur insulin infuser
Figure: Finesse insulin patch-pen
Figure: Leading diabetes device companies by product approvals, US, 2005–2010
Figure: Leading device approvals by category, US, 2005–2010